Cofoe Medical Technology Co., Ltd. (hereinafter referred to as "the Company") was established in 2009. It now has 27 wholly-owned subsidiaries, 2 holding subsidiaries, 1 participating company, and 92 branches. The company has developed into a group enterprise integrating the research and development, manufacturing, sales, and service of medical devices. The company is dedicated to improving the quality of life for the general public with more technological, humanized, and intelligent home medical products, caring for more families with high-quality products. The "Cofoe" trademark has been registered in the EU and has applied for registration in over 70 countries globally. Currently, the main focus is on the research and production of over 600 categories of products, including Class I 6864 medical consumables and dressings, and Class 6826 physical therapy and rehabilitation equipment. After years of accumulation, the company has developed capabilities in the research, production, sales, and service of smart medical products. It currently holds over 150 Class I medical device filing certificates, more than 70 medical device registration certificates, and 121 patents. The company now offers nearly 10,000 types of products, covering a wide range from medical devices for pregnant women, newborns, and infants, to those for elderly care at home. Among these, the market share of six major product lines, including wheelchairs, blood glucose meters, sphygmomanometers, oxygen generators, hearing aids, and walking sticks, leads the industry in rehabilitation products. The company closely collaborates with well-known large and medium-sized chain pharmacies across the country, such as Laobaixing, Yifeng, Qianjin, Sinopharm Holding, Dacanlin, and Haiwang Xingchen. Through the rapid development of online sales on major e-commerce platforms, the company has cultivated a user base of considerable size and brand loyalty, with its products entering over 20 million households. The company has a dedicated R&D center and factory, standardized laboratory centers, and first-class production equipment, along with the implementation of ISO9001:2000 and ISO13485 quality systems, providing reliable assurance for product development and production quality. In the future, the company will increase investment in scientific research, produce more technological, innovative, humanized, and intelligent adaptive home medical devices, serve millions of families through comprehensive online and offline channels, and strive to make "Cofoe" a world-class, trustworthy brand of home medical devices for consumers.